RAD51B Associated Mixed Cancers (MSK, NPJ Breast Cancer 2021)

Summary

RAD51B Associated Mixed Cancers (MSK, NPJ Breast Cancer 2021) is a study catalogued by cBioPortal DataHub under the cancer-type code mixed. EvidenceHelix groups it with breast studies and lists it in the TCGA (other releases) collection.

Study description

Targeted sequencing of 19 samples with RAD51B loss-of-function variants and their matched normals. Samples confer susceptibility to hereditary breast and ovarian cancers, resulting in homologous recombination-deficient tumors.

Text as published in the source's study metadata.

Citation & PubMed

Setton et al. NPJ Breast Cancer 2021

Linked PubMed records: PMID 34635660

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

mixed_msk_tcga_2021

Short name

RAD51B

Source cancer-type code

mixed

Reference genome

not given

Source access groups

not given

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data. TCGA data are available under the Broad Institute GDAC TCGA Analysis Pipeline License; TCGA-derived records are preliminary or legacy releases.

Citations

Setton et al. NPJ Breast Cancer 2021

• PubMed record 34635660 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Breast Invasive Carcinoma (TCGA, Cell 2015)

  Whole-exome sequencing of 817 Breast Invasive Carcinoma tumor/normal pairs. The Cancer Genome Atlas (TCGA) Breast Invasive Carcinoma Project.

  BreastTCGA (other releases)Source code brcaPubMed 1

• Breast Invasive Carcinoma (TCGA, Nature 2012)

  Whole-exome sequencing (510 samples with matched normals), genomic DNA copy number arrays, DNA methylation, messenger RNA arrays, microRNA sequencing and reverse-phase protein arrays analysis on 825 primary breast can…

  BreastTCGA (other releases)Source code brcaPubMed 1

• Adenoid Cystic Carcinoma of the Breast (MSK, J Pathol. 2015)

  Whole exome sequencing of 12 breast AdCCs.

  BreastMSK studiesSource code acbcPubMed 1

• Breast Cancer (HTAN, 2022)

  An omic and multidimensional spatial (OMS) atlas generated from four serial biopsies of an individual with metastatic breast cancer during 3.5 years of therapy. This resource links detailed, longitudinal clinical meta…

  BreastOther published and consortium studiesSource code brcaPubMed 1

• Breast Cancer (METABRIC, Nature 2012 & Nat Commun 2016)

  Targeted sequencing of 2509 primary breast tumors with 548 matched normals.

  BreastOther published and consortium studiesSource code brcaPubMed 3

• Breast Cancer (MSK, Cancer Cell 2018)

  Targeted Sequencing of tumor/normal sample pairs from 1918 Breast cancers.

  BreastMSK studiesSource code breastPubMed 1

• Breast Cancer (MSK, Clinical Cancer Res 2020)

  Whole-exome and MSK-IMPACT sequencing of 60 tumor/normal matched samples.

  BreastMSK studiesSource code brcaPubMed 1

• Breast Cancer (MSK, Nature Cancer 2020)

  Targeted sequencing of pre- and post-treatment tumor/cfDNA samples from 51 Breast Cancer patients to understand the mechanisms of resistance to Alepelisib.

  BreastMSK studiesSource code breastPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.